These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 11129286

  • 1. Evaluation of combined vaccinia virus-mediated antitumor gene therapy with p53, IL-2, and IL-12 in a glioma model.
    Chen B, Timiryasova TM, Andres ML, Kajioka EH, Dutta-Roy R, Gridley DS, Fodor I.
    Cancer Gene Ther; 2000 Nov; 7(11):1437-47. PubMed ID: 11129286
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of cytokine toxicity induced by vaccinia virus-mediated IL-2 and IL-12 antitumour immunotherapy.
    Chen B, Timiryasova TM, Gridley DS, Andres ML, Dutta-Roy R, Fodor I.
    Cytokine; 2001 Sep 21; 15(6):305-14. PubMed ID: 11594797
    [Abstract] [Full Text] [Related]

  • 3. Antitumor effect of vaccinia virus in glioma model.
    Timiryasova TM, Li J, Chen B, Chong D, Langridge WH, Gridley DS, Fodor I.
    Oncol Res; 1999 Sep 21; 11(3):133-44. PubMed ID: 10527073
    [Abstract] [Full Text] [Related]

  • 4. Replication-deficient vaccinia virus gene therpay vector: evaluation of exogenous gene expression mediated by PUV-inactivated virus in glioma cells.
    Timiryasova TM, Chen B, Fodor I.
    J Gene Med; 2001 Sep 21; 3(5):468-77. PubMed ID: 11601760
    [Abstract] [Full Text] [Related]

  • 5. Low-dose vaccinia virus-mediated cytokine gene therapy of glioma.
    Chen B, Timiryasova TM, Haghighat P, Andres ML, Kajioka EH, Dutta-Roy R, Gridley DS, Fodor I.
    J Immunother; 2001 Sep 21; 24(1):46-57. PubMed ID: 11211148
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW, Li D, McQuone SJ, Ralston R.
    Laryngoscope; 2005 Mar 21; 115(3):391-404. PubMed ID: 15744147
    [Abstract] [Full Text] [Related]

  • 9. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
    Komata T, Kondo Y, Koga S, Ko SC, Chung LW, Kondo S.
    Gene Ther; 2000 Dec 21; 7(24):2071-9. PubMed ID: 11223987
    [Abstract] [Full Text] [Related]

  • 10. Recombinant vaccinia virus expressing interleukin-2 invokes anti-tumor cellular immunity in an orthotopic murine model of head and neck squamous cell carcinoma.
    Dasgupta S, Bhattacharya-Chatterjee M, O'Malley BW, Chatterjee SK.
    Mol Ther; 2006 Jan 21; 13(1):183-93. PubMed ID: 16125469
    [Abstract] [Full Text] [Related]

  • 11. Gene therapy for head and neck cancer using vaccinia virus expressing IL-2 in a murine model, with evidence of immune suppression.
    Qin H, Valentino J, Manna S, Tripathi PK, Bhattacharya-Chatterjee M, Foon KA, O'Malley BW, Chatterjee SK.
    Mol Ther; 2001 Dec 21; 4(6):551-8. PubMed ID: 11735339
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combination of pGL1-TNF-alpha gene and radiation (proton and gamma-ray) therapy against brain tumor.
    Gridley DS, Li J, Kajioka EH, Andres ML, Moyers MF, Slater JM.
    Anticancer Res; 2000 Dec 21; 20(6B):4195-203. PubMed ID: 11205248
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. RG-2 glioma growth attenuation and severe brain edema caused by local production of interleukin-2 and interferon-gamma.
    Tjuvajev J, Gansbacher B, Desai R, Beattie B, Kaplitt M, Matei C, Koutcher J, Gilboa E, Blasberg R.
    Cancer Res; 1995 May 01; 55(9):1902-10. PubMed ID: 7728757
    [Abstract] [Full Text] [Related]

  • 17. Intracerebral adenovirus-mediated p53 tumor suppressor gene therapy for experimental human glioma.
    Li H, Alonso-Vanegas M, Colicos MA, Jung SS, Lochmuller H, Sadikot AF, Snipes GJ, Seth P, Karpati G, Nalbantoglu J.
    Clin Cancer Res; 1999 Mar 01; 5(3):637-42. PubMed ID: 10100717
    [Abstract] [Full Text] [Related]

  • 18. Rejection of disseminated metastases of colon carcinoma by synergism of IL-12 gene therapy and 4-1BB costimulation.
    Chen SH, Pham-Nguyen KB, Martinet O, Huang Y, Yang W, Thung SN, Chen L, Mittler R, Woo SL.
    Mol Ther; 2000 Jul 01; 2(1):39-46. PubMed ID: 10899826
    [Abstract] [Full Text] [Related]

  • 19. Induction of antitumor immunity by combined immunogene therapy using IL-2 and IL-12 in low antigenic Lewis lung carcinoma.
    Tanaka M, Saijo Y, Sato G, Suzuki T, Tazawa R, Satoh K, Nukiwa T.
    Cancer Gene Ther; 2000 Nov 01; 7(11):1481-90. PubMed ID: 11129290
    [Abstract] [Full Text] [Related]

  • 20. Regional treatment of hepatic micrometastasis by adenovirus vector-mediated delivery of interleukin-2 and interleukin-12 cDNAs to the hepatic parenchyma.
    Hirschowitz EA, Naama HA, Evoy D, Lieberman MD, Daly J, Crystal RG.
    Cancer Gene Ther; 1999 Nov 01; 6(6):491-8. PubMed ID: 10608345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.